BRPI1008561A2 - vacinas vivas atenuadas - Google Patents

vacinas vivas atenuadas

Info

Publication number: BRPI1008561A2
Authority: BR; Brazil
Prior art keywords: live attenuated; attenuated vaccines; vaccines; live; attenuated
Prior art date: 2009-02-20

Application number

BRPI1008561A

Other languages

English (en)

Inventor

Tseng Chi-Wen

Francis Browning Glenn

Francis Markham Phillip

Original Assignee

Australian Poultry Crc Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-20

Filing date

2010-02-17

Publication date

2018-07-24

2009-02-20 Priority claimed from AU2009900736A external-priority patent/AU2009900736A0/en

2010-02-17 Application filed by Australian Poultry Crc Pty Ltd filed Critical Australian Poultry Crc Pty Ltd

2018-07-24 Publication of BRPI1008561A2 publication Critical patent/BRPI1008561A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)

BRPI1008561A 2009-02-20 2010-02-17 vacinas vivas atenuadas BRPI1008561A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AU2009900736A AU2009900736A0 (en)		2009-02-20	Live attenuated vaccines
PCT/AU2010/000172 WO2010094064A1 (en)	2009-02-20	2010-02-17	Live attenuated vaccines

Publications (1)

Publication Number	Publication Date
BRPI1008561A2 true BRPI1008561A2 (pt)	2018-07-24

Family

ID=42633348

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1008561A BRPI1008561A2 (pt)	2009-02-20	2010-02-17	vacinas vivas atenuadas

Country Status (10)

Country	Link
US (1)	US20120045475A1 (pt)
EP (1)	EP2398892A4 (pt)
JP (1)	JP5753098B2 (pt)
CN (1)	CN102317439B (pt)
AU (1)	AU2010215065B2 (pt)
BR (1)	BRPI1008561A2 (pt)
CA (1)	CA2750136A1 (pt)
MX (1)	MX2011007606A (pt)
RU (1)	RU2556813C2 (pt)
WO (1)	WO2010094064A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX357314B (es)	2008-09-26	2018-07-04	Ambrx Inc	Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
EP2571980A4 (en) *	2010-05-19	2014-02-26	Bioproperties Pty Ltd	METHOD RELATED TO A WEAKEN MYCOPLASMA
WO2013091040A2 (pt) *	2011-12-22	2013-06-27	Universidade Federal De Minas Gerais - Ufmg	Cepa atenuada de brucella ovis, composição vacinal e uso
US8734814B2 (en)	2012-03-02	2014-05-27	Asis Datta	Recombinant microorganisms and uses thereof
WO2014004361A1 (en) *	2012-06-27	2014-01-03	Merial Limited	Attenuated streptococcus suis vaccines and methods of making and use thereof
BR112018002919B1 (pt) *	2015-08-14	2024-02-27	Zoetis Services Llc	Composição imunogênica eficaz compreendendo uma cepa de mycoplasma bovis e usos da mesma para prevenção de doenças causadas por mycoplasma bovis
US10071149B2 (en)	2016-05-03	2018-09-11	Brigham Young University	Temperature sensitive multivalent Bordetella avium vaccines
CN105999281B (zh) *	2016-07-26	2019-02-19	河南后羿生物工程股份有限公司	禽类活病毒用冻干保护剂、制备方法及应用
CN109414037A (zh)	2016-12-15	2019-03-01	雀巢产品技术援助有限公司	调节伴侣动物中的细菌的组合物和方法
WO2018140717A1 (en) *	2017-01-27	2018-08-02	University Of Florida Research Foundation Incorporated	A food safety vaccine to control salmonella enterica and reduce campylobacter in poultry
CN107308445B (zh) *	2017-07-26	2020-11-24	山东省滨州畜牧兽医研究院	羊三联四防亚单位疫苗及其制备方法
US12390516B2 (en) *	2017-07-31	2025-08-19	Kansas State University Research Foundation	Vaccines against tick-borne diseases
CN108414751A (zh) *	2018-03-22	2018-08-17	山西省动物疫病预防控制中心	一种鸡白痢染色凝集抗原及其制备方法
CN108929864B (zh) *	2018-07-19	2021-03-23	浙江农林大学	用于预防鸡传染性法氏囊病的致弱病毒及用途
CN109758427B (zh) *	2019-02-26	2021-11-02	兆丰华生物科技(福州)有限公司	一种伪狂犬病活疫苗耐热保护剂及其制备方法和应用
WO2023032950A1 (ja) *	2021-08-30	2023-03-09	天野エンザイム株式会社	向上したタンパク質生産性を有する微生物及びその利用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4000256A (en) *	1975-04-30	1976-12-28	Merck & Co., Inc.	Varicella vaccine and process for its preparation
US20040116661A1 (en) *	2000-10-26	2004-06-17	Holden David William	Streptococcal genes
EP1330473A2 (en) *	2000-10-26	2003-07-30	Imperial College Innovations Limited	Streptococcal genes
GB0308691D0 (en) *	2003-04-07	2003-05-21	Xenova Res Ltd	Vaccine preparations
US20090162401A1 (en) *	2005-02-18	2009-06-25	Buchanan John T	Streptococcus Iniae Phosphoglucomutase is a Virulence Factor and Target for Vaccine Development
RU2468083C1 (ru) *	2011-04-25	2012-11-27	Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ")	Способ получения l-аминокислоты с использованием бактерии семейства enterobacteriaceae, в которой ослаблена экспрессия генов, кодирующих транспортер лизина/аргинина/орнитина

2010
- 2010-02-17 EP EP20100743320 patent/EP2398892A4/en not_active Withdrawn
- 2010-02-17 WO PCT/AU2010/000172 patent/WO2010094064A1/en not_active Ceased
- 2010-02-17 RU RU2011138410/10A patent/RU2556813C2/ru not_active IP Right Cessation
- 2010-02-17 AU AU2010215065A patent/AU2010215065B2/en not_active Ceased
- 2010-02-17 JP JP2011550380A patent/JP5753098B2/ja not_active Expired - Fee Related
- 2010-02-17 CA CA2750136A patent/CA2750136A1/en not_active Abandoned
- 2010-02-17 CN CN201080007679.7A patent/CN102317439B/zh not_active Expired - Fee Related
- 2010-02-17 BR BRPI1008561A patent/BRPI1008561A2/pt not_active IP Right Cessation
- 2010-02-17 US US13/202,534 patent/US20120045475A1/en not_active Abandoned
- 2010-02-17 MX MX2011007606A patent/MX2011007606A/es active IP Right Grant

Also Published As

Publication number	Publication date
AU2010215065A1 (en)	2011-08-11
JP2012518388A (ja)	2012-08-16
WO2010094064A1 (en)	2010-08-26
US20120045475A1 (en)	2012-02-23
RU2011138410A (ru)	2013-03-27
CA2750136A1 (en)	2010-08-26
CN102317439B (zh)	2015-11-25
RU2556813C2 (ru)	2015-07-20
MX2011007606A (es)	2011-08-08
JP5753098B2 (ja)	2015-07-22
EP2398892A4 (en)	2013-03-06
CN102317439A (zh)	2012-01-11
AU2010215065B2 (en)	2014-05-15
EP2398892A1 (en)	2011-12-28

Publication	Publication Date	Title
BRPI1008561A2 (pt)	2018-07-24	vacinas vivas atenuadas
DK3170508T3 (da)	2020-01-02	Vaccineformuleringer
DK3661211T3 (da)	2021-09-27	Billedforudsigelse-afkodningsfremgangsmåde
FR21C1022I2 (fr)	2024-03-29	Parvovirus vivants atténués
DK3033945T3 (da)	2019-09-23	Slagteanlæg
EP2427219A4 (en)	2014-05-21	FAN AUTOCLAVE
IT1395108B1 (it)	2012-09-05	Caldaia
DK2394882T3 (da)	2014-02-03	Funktionssikret scanner
BRPI0816686A2 (pt)	2015-03-17	Cepas de micoplasma atenuadas vivas
EP2515938A4 (en)	2013-08-28	IMMUNOGENIC COMPOSITIONS
BR112014005756A2 (pt)	2017-03-28	vacina
DK2635269T3 (da)	2019-08-26	Kombinationspræparat
EP2609931A4 (en)	2014-06-04	IMMUNOGENIC COMPOSITION
FR2952291B3 (fr)	2011-10-28	Grill
EP2543387A4 (en)	2013-06-19	MUCOSA VACCINE
EP2498815A4 (en)	2014-03-19	VACCINE COMPOSITION
DK2279652T3 (da)	2012-11-26	Kultivator
EP2433056A4 (en)	2015-12-09	COOKER
BRPI1009979A2 (pt)	2016-03-15	aveso
BRPI0919102A2 (pt)	2015-12-08	vacinas de salmonella não-tifóide
FR2949540B3 (fr)	2011-08-26	Cheminee
FI20105027A0 (fi)	2010-01-15	Höyrykattila
SMT201600163B (it)	2016-07-01	Formulazione alimentare comprendente glicogeno
FR2955787B1 (fr)	2012-04-20	Autoclave torique
FI20095972A0 (fi)	2009-09-22	Tulisija

Legal Events

Date	Code	Title	Description
2018-07-31	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-11-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2482 DE 31-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.